FDA Drug Recalls

18,003 recalls, newest first

Apr 13, 2022 Class II · Moderate risk

Geodon for injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0049-3920-83 D-1112-2022

Apr 13, 2022 Class II · Moderate risk

Sumatriptan Succinate Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 62756-522-69 D-1111-2022

Apr 13, 2022 Class II · Moderate risk

Metoprolol tablets 50 mg

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 57664-0477-52 D-1110-2022

Apr 13, 2022 Class II · Moderate risk

Pilocarpine HCL Ophthalmic Solution

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office D-1109-2022

Apr 13, 2022 Class II · Moderate risk

Tropicamide Ophthalmic Solution

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office D-1108-2022

Apr 13, 2022 Class II · Moderate risk

Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office D-1107-2022

Apr 13, 2022 Class II · Moderate risk

Triamcinolone Acetonide cream

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0168-0004-15 D-1106-2022

Apr 13, 2022 Class II · Moderate risk

Prednisolone Acetate Ophthalmic Suspension

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 61314-637-05 D-1105-2022

Apr 13, 2022 Class II · Moderate risk

Pantoprazole Sodium for Injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0781-3232-95 D-1104-2022

Apr 13, 2022 Class II · Moderate risk

Ondansetron HCL

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 65862-188-30 D-1103-2022

Apr 13, 2022 Class II · Moderate risk

Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 61314-631-36 D-1102-2022

Apr 13, 2022 Class II · Moderate risk

Diphenhydramine HCl oral solution

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0121-0978-10 D-1101-2022

Apr 13, 2022 Class II · Moderate risk

Verapamil HCL

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 04094-011-01 D-1100-2022

Apr 13, 2022 Class II · Moderate risk

Thrombin JMI

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 60793-215-05 D-1099-2022

Apr 13, 2022 Class II · Moderate risk

Epinephrine

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 04094-933-01 D-1098-2022

Apr 13, 2022 Class II · Moderate risk

Depo-Medrol

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0009-3475-01 D-1097-2022

Apr 13, 2022 Class II · Moderate risk

Depo-Medrol

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0009-3073-03 D-1096-2022

Apr 13, 2022 Class II · Moderate risk

Bupivacaine Hydrochloride

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0409-1163-01 D-1095-2022

Apr 13, 2022 Class II · Moderate risk

Labetalol Hydrochloride Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 49884-122-01 D-1094-2022

Apr 13, 2022 Class II · Moderate risk

Prazosin Hydrochloride Capsules

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0378-1101-01 D-1093-2022

Apr 13, 2022 Class II · Moderate risk

Loperamide Hydrochloride capsules

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0378-2100-01 D-1092-2022

Apr 13, 2022 Class II · Moderate risk

Duraclon (clonidine HCl injection, USP)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 67457-218-10 D-1091-2022

Apr 13, 2022 Class II · Moderate risk

Proventil HFA

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0085-1132-04 D-1090-2022

Apr 13, 2022 Class II · Moderate risk

Celestone Soluspan

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0085-4320-01 D-1089-2022

Apr 13, 2022 Class II · Moderate risk

Levofloxacin Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-6352-61 D-1088-2022

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061